Creso Pharma Ltd (ASX: CPH) is a cannabis sector company that can deliver products with standardised dosing and formulations. It follows Good Manufacturing Practices (GMP) standards. The key aim is to deliver pharmaceutical expertise with delivery of highest quality products in the cannabis space. In this regard, therapeutic-grade Nutraceuticals that have been derived from hemp is another class of products that the group is working on. The group is developing presence in many markets and aims to offer a diverse portfolio of solutions across the globe. The products developed belong to categories ranging from Therapeutics, Animal health, nutraceuticals, topicals and lifestyle.